December 27th 2024, 10:00pm
Treatment with five-fraction SBRT for prostate cancer may be more convenient than receiving traditional radiation therapy techniques, an expert said.
December 27th 2024, 2:00pm
An MPN advocate used his personal experiences to inform his dedication to patient-centered research and support programs for patients.
December 26th 2024, 10:00pm
A patient advocate discusses the difficulties of finding and participating in clinical trials for MPNs, and the impact on research and treatment development.
December 26th 2024, 8:00pm
An expert spoke with CURE® about the importance of information that can be gained from genetic testing for patients with breast cancer.
December 26th 2024, 2:00pm
The treatment combination was found to reduce the risk of follicular lymphoma progression or death by 57%, a study has shown.
December 24th 2024, 10:00pm
A health care professional talks about the importance of a supportive care team, especially since every patient with MPNs presents differently.
December 19th 2024, 8:00pm
Targeting the estrogen receptor and HER2 pathways improved progression-free survival in patients with HR-positive, HER2-positive metastatic breast cancer.
December 19th 2024, 2:00pm
CURE® spoke with an expert about follicular lymphoma, a disease that is still considered incurable.
December 18th 2024, 10:01pm
A panelist discusses how polycythemia vera (PV) is a rare myeloproliferative neoplasm (MPN) characterized by excessive red blood cell production, primarily affecting older adults with JAK2 mutations, and while it can be managed with treatment, patients face increased risks of blood clots and potential progression to more serious conditions.
December 17th 2024, 8:00pm
An expert explained the impact that burnout can have on someone caring for a loved one with cancer.
Lymphoma Survivor Discusses the Importance of Finding Humor in Cancer
A Cancer Survivor Rethinks Cancer Ghosting
A Story of Staying Active After a Lung Cancer Diagnosis
Experts Discuss New Advances in Bladder Cancer Following ESMO 2025